Osteogenex

Small molecule against the validated target Sclerostin to increase bone density

placeOverland Park, Kansas, United States calendar_todayFounded 2006 language osteogenex.com

Investor mix

2 investors on record.

Investor typeCountShare
Accelerator & incubator150%
Other / undisclosed150%
Coming soon